Trane Technologies (TT)

NYSEIndustrialsIndustrial - MachinerySnapshot 2026-10-15

$458.89+0.33%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Trane Technologies’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.7%

+10% or more+5%0%−5%−10% or less

17.58 → 17.70 EPS · FY ending Dec 31, 2027 · 15 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 14 to 15; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Maintain strong cash flow and effective capital deployment	The company manages capital well, generating strong cash flow.	Intact	Annual cash from operations falls significantly below $2.5 billion	Cash from operations: $1.088B FY2026-Q2; GAAP. Published target: Sustain cash from operations near or above $2.5 billion annually. Target period is not explicitly aligned with this observation. Source published Jul 30, 20261,087,700,000 USD · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
EPS reaches between $14.75 and $14.95 in 2026	A primary condition in Trane Technologies's published investment case. The stated target is EPS between $14.75 and $14.95.	Intact	EPS falls below $13.0 in FY26	Diluted EPS: $4.16 per share FY2026-Q2; GAAP. Published target: EPS between $14.75 and $14.95. Target period is not explicitly aligned with this observation. Source published Jul 30, 20264.16 USD/share · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 9a3d49fb-768a-4b7a-90c7-0920ba5f42e5. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Achieve at least 9.5% revenue growth in 2026	A primary condition in Trane Technologies's published investment case. The stated target is >=9.5% YoY revenue growth.	Intact	YoY revenue growth falls below ~7% in FY26	Revenue growth: 10.56% FY2026-Q2; GAAP. Published target: >=9.5% YoY revenue growth. Target period is not explicitly aligned with this observation. Source published Jul 30, 202610.564875 percent · calculatedSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 9a3d49fb-768a-4b7a-90c7-0920ba5f42e5. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$17.70

$17.08 → $17.70 · observed estimates

FY2027 revenue$26.14B

$25.43B → $26.14B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$17.08	$25,427,685,090	24 / 23
2026-07-25	$17.09	$25,433,437,260	24 / 23
2026-07-26	$17.09	$25,433,437,260	24 / 23
2026-07-27	$17.09	$25,418,405,232	13 / 17
2026-07-28	$17.09	$25,418,405,232	13 / 17
2026-07-29	$17.09	$25,433,437,260	24 / 23
2026-07-30	$17.09	$25,418,405,232	14 / 17
2026-07-31	$17.18	$25,540,129,820	24 / 23
2026-08-01	$17.27	$25,658,258,231	14 / 17
2026-08-02	$17.40	$25,786,649,980	24 / 23
2026-08-03	$17.38	$25,765,971,415	14 / 17
2026-08-04	$17.38	$25,765,971,415	14 / 17
2026-08-05	$17.38	$25,765,971,415	14 / 17
2026-08-06	$17.38	$25,765,971,415	14 / 17
2026-08-08	$17.38	$25,765,971,415	14 / 17
2026-08-09	$17.47	$25,831,303,690	24 / 23
2026-08-10	$17.38	$25,765,971,415	14 / 17
2026-08-12	$17.38	$25,765,971,415	14 / 17
2026-08-13	$17.47	$25,831,303,690	24 / 23
2026-08-14	$17.38	$25,765,971,415	14 / 17
2026-08-15	$17.38	$25,765,971,415	14 / 17
2026-08-16	$17.38	$25,765,971,415	14 / 17
2026-08-17	$17.38	$25,765,971,415	14 / 17
2026-08-18	$17.38	$25,765,971,415	14 / 17
2026-08-19	$17.38	$25,765,971,415	14 / 17
2026-08-20	$17.50	$25,854,495,683	14 / 17
2026-08-21	$17.50	$25,854,495,683	14 / 17
2026-08-22	$17.51	$25,865,920,467	14 / 17
2026-08-23	$17.51	$25,865,920,467	14 / 17
2026-08-24	$17.51	$25,865,920,467	14 / 17
2026-08-25	$17.51	$25,865,920,467	14 / 17
2026-08-26	$17.51	$25,865,920,467	14 / 17
2026-08-27	$17.51	$25,865,920,467	14 / 17
2026-08-28	$17.51	$25,865,920,467	14 / 17
2026-08-29	$17.51	$25,865,920,467	14 / 17
2026-08-30	$17.51	$25,865,920,467	14 / 17
2026-08-31	$17.51	$25,865,920,467	14 / 17
2026-09-01	$17.51	$25,865,920,467	14 / 17
2026-09-02	$17.53	$25,865,920,467	14 / 17
2026-09-03	$17.58	$25,908,562,069	14 / 17
2026-09-04	$17.58	$25,908,562,069	14 / 17
2026-09-05	$17.58	$25,908,562,069	14 / 17
2026-09-06	$17.58	$25,908,562,069	14 / 17
2026-09-07	$17.58	$25,908,562,069	14 / 17
2026-09-08	$17.58	$25,908,562,069	14 / 17
2026-09-09	$17.58	$25,908,562,069	14 / 17
2026-09-10	$17.58	$25,908,562,069	14 / 17
2026-09-11	$17.58	$25,908,562,069	14 / 17
2026-09-12	$17.58	$25,908,562,069	14 / 17
2026-09-13	$17.58	$25,908,562,069	14 / 17
2026-09-14	$17.58	$25,908,562,069	14 / 17
2026-09-15	$17.58	$25,908,562,069	14 / 17
2026-09-16	$17.56	$25,904,262,069	14 / 17
2026-09-17	$17.56	$25,904,262,069	14 / 17
2026-09-18	$17.56	$25,904,262,069	14 / 17
2026-09-19	$17.56	$25,904,262,069	14 / 17
2026-09-20	$17.57	$25,914,512,069	14 / 17
2026-09-21	$17.57	$25,914,512,069	14 / 17
2026-09-22	$17.57	$25,914,512,069	14 / 17
2026-09-23	$17.57	$25,914,512,069	14 / 17
2026-09-24	$17.57	$25,914,512,069	14 / 17
2026-09-25	$17.57	$25,914,512,069	14 / 17
2026-09-26	$17.61	$25,983,630,542	14 / 17
2026-09-27	$17.61	$25,983,630,542	14 / 18
2026-09-28	$17.61	$25,983,630,542	14 / 18
2026-09-29	$17.62	$25,986,341,917	14 / 18
2026-09-30	$17.62	$25,986,341,917	14 / 18
2026-10-01	$17.66	$26,057,528,102	14 / 18
2026-10-02	$17.66	$26,057,528,102	14 / 18
2026-10-03	$17.66	$26,057,523,754	14 / 18
2026-10-04	$17.66	$26,057,523,754	14 / 18
2026-10-05	$17.66	$26,057,523,754	14 / 18
2026-10-06	$17.66	$26,057,523,754	14 / 18
2026-10-07	$17.65	$26,053,476,135	14 / 18
2026-10-08	$17.65	$26,053,496,359	14 / 18
2026-10-09	$17.65	$26,053,496,359	14 / 18
2026-10-10	$17.65	$26,053,496,359	14 / 18
2026-10-11	$17.65	$26,057,837,433	15 / 18
2026-10-12	$17.65	$26,057,837,433	15 / 18
2026-10-13	$17.65	$26,057,837,433	15 / 18
2026-10-14	$17.66	$26,071,078,342	15 / 18
2026-10-15	$17.70	$26,136,840,024	15 / 19

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	13	11	2
2026-06-01	14	10	2
2026-07-01	13	11	1
2026-08-01	13	11	1
2026-09-01	15	11	0
2026-10-01	17	11	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 17 Buy / Strong Buy · 11 Hold · 1 Sell / Strong Sell

1 upgrades0 downgrades1 maintains

Recent actions · Sep 16–Oct 15 · 2 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Mizuho SecuritiesOct 15 · prior May 1

$475.00 → $485.00+2.1%

Goldman SachsOct 14

$565.00New observation · no comparable prior

Wells FargoSep 24

$536.00New observation · no comparable prior

$0$310.75$621.50

1 raises · 0 cuts · 0 unchanged · 2 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Maintain strong cash flow and effective capital deploymentCash from operations: $1.088B
EPS reaches between $14.75 and $14.95 in 2026Diluted EPS: $4.16 per share
Achieve at least 9.5% revenue growth in 2026Revenue growth: 10.56%

Next proof point

Oct 29, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.1%Typical daily move · historical

Downside history

-16.2%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Trane Technologies outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a durable compounder, focusing on steady revenue and earnings growth. The current thesis is stable, with management emphasizing growth targets and disciplined capital allocation.

What's priced into Trane Technologies

The market appears to have priced in an elevated valuation due to weak execution quality and recent performance issues. There is an expectations gap, suggesting that the stock may be seen as unjustified compared to its peers.

What the fundamentals likely do

Management is on track to achieve double-digit revenue growth and a targeted GAAP EPS of approximately $15.00 for 2026. However, there is a moderate risk due to the company's recent history of misses, which could impact future performance.

What Trane Technologies hinges on

The thesis hinges on the performance of sector bellwethers like GEV, PH, and EMR, which could either support or undermine TT's growth. Additionally, any reversal in guidance from TT would significantly impact credibility and investor sentiment.